Parameter
| Biomarker | NMP22 | Full name | Nuclear Matrix Protein 22 | Molecular Type | Protein (nuclear-matrix protein) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis (apoptosis-related) |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Urine (NMP22® assay kit) | ||
| Pathobiological Mechanisms | Quantifies NMP22 released during tumor-cell apoptosis; sensitivity superior to cytology | ||||
| Clinical Availability Status | FDA-cleared; clinic-ready quantitative kit | ||||
| Notes and Dynamics | False positives in cystitis, BPH or after instrumentation; recommend adjuvant use | ||||